mdlinx mdlinx
Latest (82) Full Text Articles (1263) Focus on Anxiety Disorders Article Summary

Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study
Psychotherapy and Psychosomatics, Exclusive Author Commentary  Clinical Article

Fiedorowicz JG et al. – The results provide evidence that chronicity of mood symptoms contribute to vasculopathy in a dose–dependent fashion. Patients with more manic/hypomanic symptoms had poorer endothelial function. First–generation antipsychotic exposure was associated with arterial stiffness, evidenced by higher augmentation pressure, perhaps secondary to elevated blood pressure. Vascular phenotyping methods may provide a promising means of elucidating the mechanisms linking mood disorders to vascular disease.

Methods
  • Participants with mood disorders were recruited for the National Institute of Mental Health Collaborative Depression Study (CDS) and followed prospectively.
  • A cross-sectional metabolic and vascular function evaluation was performed on a sub-sample near completion after a mean follow-up of 27 years.

Results
  • A total of 35 participants from the University of Iowa (33) and Washington University (2) sites of the CDS consented to a metabolic and vascular function assessment at the Iowa site.
  • In multivariate linear regression, controlling for age, gender, and smoking, manic/hypomanic, but not depressive, symptom burden was associated with lower flow-mediated dilation.
  • Cumulative exposure to antipsychotics and mood stabilizers was associated with elevated augmentation pressure and mean aortic systolic blood pressure.
  • This appeared specifically related to first-generation antipsychotic exposure and mediated by increases in brachial systolic pressure.
  • Although second-generation antipsychotics were associated with dyslipidemia and insulin resistance, they were not associated with vasculopathy.

In a prior analysis of 435 individuals with bipolar disorder from the Collaborative Depression Study (CDS), we found manic/hypomanic symptom burden (chronicity of clinically significant manic/hypomanic symptomatology) was significantly associated with cardiovascular mortality (Fiedorowicz et al. Psychosom Med 2009). This appeared to account for the greater risk of cardiovascular mortality in bipolar I, relative to bipolar II disorder as observed in the CDS sample and the only prior study to assess mortality differences by bipolar subtype (Angst F et al. J Affect Disord 1994). We were interested in replicating and extending the prior finding. To do so, we recruited a small subset of participants from the CDS, whose course of illness had been prospectively assessed for over a quarter century through participation, for a quantitative metabolic and vascular phenotyping assessment. We analogously found a dose-response relationship between manic/hypomanic symptom burden and endothelial dysfunction, based on a relationship with poorer flow-mediated but not nitroglycerin-mediated vasodilation. While difficult to study as reliable data is seldom available, the assessment of a dose-response between the long-term chronicity of illness and vascular outcomes circumvents some of the issues related to selection bias in case control studies (e.g. inpatient registry compared to national data) and provides additional evidence for a causal relationship between bipolar disorder and vascular disease. Such methods may assist in the identification of the most relevant mechanisms mediating the well-established relationship between bipolar disorder and vascular mortality (reviewed by Murray et al. Curr Psychiatry Rep 2009; Weiner M et al. Ann Clin Psychiatry 2011). References: Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-81. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG. Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study. Psychotherapy and Psychosomatics 2012;81:235-43. Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009;71:598-606. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep 2009;11:475-80. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011;23:40-7.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2013

1 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

2 Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study Journal of Psychiatric Research, March 14, 2014    Clinical Article
Exclusive Author Commentary

3 Selective serotonin reuptake inhibitor drug interactions in patients receiving statins The Journal of Clinical Psychiatry, March 5, 2014    Clinical Article

4 Salivary exoglycosidases as a markers of alcohol dependence Alcohol and Alcoholism , March 17, 2014    Clinical Article

5 Effect of reiki therapy on pain and anxiety in adults: an in-depth literature review of randomized trials with effect size calculations Pain Management Nursing, March 19, 2014    Review Article    Clinical Article

6 Cognitive effects of statin medications CNS Drugs, February 18, 2014    Clinical Article

7 A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? International Clinical Psychopharmacology, January 15, 2014    Review Article    Clinical Article

8 Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis Schizophrenia Bulletin, March 25, 2014    Evidence Based Medicine

9 Agomelatine: A new option for treatment of depression? Expert Opinion on Pharmacotherapy, February 14, 2014    Clinical Article

10 Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol Full Text BMC Complementary and Alternative Medicine, March 12, 2014    Free full text    Clinical Article

11 Bipolar or borderline: A clinical overview Acta Psychiatrica Scandinavica, February 27, 2014    Review Article

12 Hypnotherapy is more effective than nicotine replacement therapy for smoking cessation: Results of a randomized controlled trial Complementary Therapies in Medicine, March 3, 2014    Clinical Article

13 Pregabalin in acute treatment of anxious depression: A case series Psychiatry Research, February 13, 2014    Clinical Article

14 Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis Psychiatry Research, March 10, 2014    Evidence Based Medicine

15 A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia Schizophrenia Research, March 26, 2014    Clinical Article

16 Psychodynamic psychotherapy versus cognitive behavior therapy for social anxiety disorder: An efficacy and partial effectiveness trial Depression and Anxiety, February 28, 2014    Clinical Article

17 Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study American Journal of Psychiatry, February 7, 2014    Clinical Article

18 Electronic cigarette use outcome expectancies among college students Addictive Behaviours, March 11, 2014    Clinical Article

19 Gabapentin treatment for alcohol dependence: A randomized clinical trial JAMA Internal Medicine, January 10, 2014    Evidence Based Medicine    Clinical Article

20 Cannabis and psychosis: Neurobiology Full Text Indian Journal of Psychiatry, January 17, 2014    Free full text    Review Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close